Tcr2 Therapeutics Inc (TCRR) is around the top of the Healthcare sector according to InvestorsObserver.
TCRR received an overall rating of 55, which means that it scores higher than 55% of stocks. Additionally, Tcr2 Therapeutics Inc scored a 76 in the Healthcare sector, ranking it higher than 76% of stocks in that sector.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style.
Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Tcr2 Therapeutics Inc Stock Today?
Tcr2 Therapeutics Inc (TCRR) stock is trading at $24.97 as of 12:57 PM on Wednesday, Jan 27, a drop of -$2.24, or -8.23% from the previous closing price of $27.21. The stock has traded between $24.25 and $27.08 so far today. Volume today is low. So far 443,992 shares have traded compared to average volume of 660,106 shares.
Click Here to get the full Stock Score Report on Tcr2 Therapeutics Inc (TCRR) Stock.
